title: We do not have evidence that avoidance of succinylcholine in patients receiving statins will improve outcomes.
authors.forename: John F
authors.initials: JF
authors.lastname: Butterworth
mesh_terms: D000924:Anticholesteremic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D008297:Male; D009467:Neuromuscular Depolarizing Agents / Q000009:adverse effects*; D003473:Neuromuscular Nondepolarizing Agents / Q000009:adverse effects*; D013390:Succinylcholine / Q000009:adverse effects*
chemical_list: D000924:Anticholesteremic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D009467:Neuromuscular Depolarizing Agents; D003473:Neuromuscular Nondepolarizing Agents; D013390:Succinylcholine